AccessibilityHelpAbout Us
Shandong Weigao Group Medical Polymer logo

Shandong Weigao Group Medical Polymer(OTC) SHWGY

Market Cap$1.84BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)-73%
5 Year-71%
1 Year-51%
1 Month-14%
$1.64
+10.81%
+0.16Today
Shandong Weigao Group Medical Polymer last closing stock price
MetricPriceDate
Last closeUSD 1.642026-09-23
Shandong Weigao Group Medical Polymer stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+9.63%USD 1.502026-09-14
1 month-13.68%USD 1.902026-08-18
3 month+9.92%USD 1.492026-06-25
Year to date-37.31%USD 2.622025-12-31
1 year-50.84%USD 3.342025-08-06
3 year-50%USD 3.282023-09-21
5 year-71.09%USD 5.672021-09-24
Since inception-72.93%USD 6.062011-05-09

Shandong Weigao Group Medical Polymer Financials at a Glance

Market Cap

$1.84BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CN¥26.49B

Net Income (TTM)

CN¥3.33B

EPS (TTM)

$0.17

P/E Ratio

9.40

Dividend

$0.09

Beta (Volatility)

0.00 (Low)

Price

$1.64

Volume

30

Open

$1.64

Previous Close

$1.64

Daily Range

$1.64 - $1.64

52-Week Range

$1.48 - $3.24

Estimated Earnings Date

Mar 24, 2026

SHWGY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Shandong Weigao Group Medical Polymer

Shandong Weigao Group Medical Polymer Company Limited is a leading manufacturer of disposable medical products, established in 2000 and based in Weihai, China. The company specializes in the research, development, and distribution of a wide range of medical devices and supplies, catering to both domestic and international markets.

Products and Services
  • Disposable medical products including infusion sets and syringes
  • Orthopedic devices and interventional tools for various medical applications
  • Pharma packaging products and blood management solutions
Growth Outlook
  • Revenue of CNY 6.77 billion in Q2 2026, showing strong demand
  • Net income increased to CNY 765 million in Q2 2026, reflecting profitability
  • Operating income margin improved to 16.5% in Q2 2026, indicating operational efficiency
Financial Highlights
  • Trailing twelve months (TTM) revenue of CNY 26.5 billion, demonstrating consistent growth
  • Net profit margin of 10.1% TTM, showcasing effective cost management
  • Current ratio of 3.09 TTM, indicating strong liquidity position
Shandong Weigao Group Medical Polymer Company Limited operates in the healthcare sector, focusing on medical instruments and supplies. The company has established a robust portfolio of products that cater to various medical needs, including wound care, anesthesia consumables, and blood management equipment. With a significant market presence in China and expanding international reach, the company is well-positioned for future growth. Recent financial performance highlights a strong upward trend, with a notable increase in revenue and net income in the latest quarter. The operating income margin reflects improved efficiency, which is crucial for sustaining profitability in a competitive market. The company's liquidity position, as indicated by a current ratio above 3, suggests a solid ability to meet short-term obligations. Investors may find Shandong Weigao Group Medical Polymer Company Limited an attractive opportunity due to its comprehensive product offerings, strong financial performance, and positive growth outlook in the medical device industry.
AI Generated • Sep 17, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

13,307

CEO

Rinan Cong, MBA

Website

www.weigaogroup.com

Headquarters

Weihai, SD 264210, CN

SHWGY Financials

Key Financial Metrics (TTM)

Gross Margin

45.56%

Operating Margin

12.13%

Net Income Margin

10.13%

Return on Equity

5.64%

Return on Capital

6.26%

Return on Assets

3.85%

Earnings Yield

10.64%

Dividend Yield

5.45%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.84BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.12B

Volume

30

Avg. Volume

154.516

Financials (TTM)

Gross Profit

CN¥12.47B

Operating Income

CN¥3.86B

EBITDA

CN¥5.95B

Operating Cash Flow

CN¥5.45B

Capital Expenditure

-CN¥2.32B

Free Cash Flow

CN¥3.13B

Cash & ST Invst.

CN¥8.92B

Total Debt

CN¥4.96B

Shandong Weigao Group Medical Polymer Performance Analysis

Shandong Weigao Group Medical Polymer annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CNY 2,041,588,504-0.3%
20232023-12-31CNY 1,867,240,593-8.5%
20242024-12-31CNY 1,818,452,514-2.6%
20252025-12-31CNY 1,862,556,4082.4%
Shandong Weigao Group Medical Polymer sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-2.8%
Q22025-06-303.0%
Q42025-12-31-0.4%
Q22026-06-302.3%
Shandong Weigao Group Medical Polymer annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CNY 0.3616.1%
20232023-12-31CNY 0.25-31.0%
20242024-12-31CNY 0.251.0%
20252025-12-31CNY 0.20-21.8%
Shandong Weigao Group Medical Polymer sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-16.7%
Q22025-06-3010.0%
Q42025-12-31-40.9%
Q22026-06-3030.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CN¥6.77B

+2.1%

Gross Profit

CN¥3.14B

-7.1%

Gross Margin

46.29%

N/A

Market Cap

$1.84BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$138.38K

N/A

Employees

13,307

N/A

Net Income

CN¥765.57M

-30.9%

EBITDA

CN¥1.62B

-4.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CN¥8.92B

+13.4%

Total Debt

CN¥4.96B

+20.1%

Accounts Receivable

CN¥8.56B

+7.5%

Inventory

CN¥2.55B

+10.1%

Long Term Debt

CN¥2.76B

-20.0%

Short Term Debt

CN¥2.19B

+225.5%

Return on Assets

3.85%

N/A

Return on Invested Capital

5.63%

N/A

Free Cash Flow

CN¥1.08B

+5.4%

Operating Cash Flow

CN¥1.08B

+5.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ANSLFAnsell Limited
$21.64+0.00%
TCHBFTecan Group AG
$261.16+0.00%
SNPHYSanten Pharmaceutical Co., Ltd.
$11.05+2.79%
MAHLYMediPal Holdings Corporation
$18.76+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
GLNDGreenland Energy
$5.50+2.80%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.90-3.45%
INTCIntel
$124.16-2.54%
AALAmerican Airlines Group
$13.84+3.67%

Questions About SHWGY

What is the current price of Shandong Weigao Group Medical Polymer?

Shandong Weigao Group Medical Polymer is trading at $1.64 per share.

What is the 52-week range for Shandong Weigao Group Medical Polymer?

Over the past 52 weeks, Shandong Weigao Group Medical Polymer has traded between $1.48 and $3.24.

How much debt does Shandong Weigao Group Medical Polymer have?

As of the most recent reporting period, Shandong Weigao Group Medical Polymer reported total debt of CN¥846.12M.

How much cash does Shandong Weigao Group Medical Polymer have on hand?

Shandong Weigao Group Medical Polymer reported CN¥1.29B in cash and cash equivalents in its most recent financial results.

What is Shandong Weigao Group Medical Polymer’s dividend yield?

Shandong Weigao Group Medical Polymer currently has a dividend yield of 5.45%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services